SOLYMBIC Trademark

Trademark Overview


On Monday, April 11, 2016, a trademark application was filed for SOLYMBIC with the United States Patent and Trademark Office. The USPTO has given the SOLYMBIC trademark a serial number of 86971830. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, July 13, 2020. This trademark is owned by Amgen Inc.. The SOLYMBIC trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances used for the treatment of bone, joint, intestine, colon, skin, lung, eye, bladder, blood cells, and blood vessel diseases and disorders; pharmaceutical preparations and substances for the treatment of autoimmune and immune system, inflammatory, inflammatory bowel, gastrointestinal, musculoskeletal, dermatological, pulmonary, respiratory, oncological, and ophthalmic diseases and disorders; pharmaceutical preparations and substances used for the treatment of arthritis, rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, axial spondyloarthritis, juvenile idiopathic arthritis, enthesitis related arthritis, osteoarthritis, peripheral spondyloarthritis, acute disc prolapse, inflammatory bowel disease, Crohn's disease, ulcerative colitis, Intestinal Behçet's Disease, chronic pouchitis, small bowel lesions, Hermansky-Pudlak syndrome, psoriasis, psoriasis vulgaris, psoriasis arthropica, plaque psoriasis, hidradenitis suppurativa, inters...
solymbic

General Information


Serial Number86971830
Word MarkSOLYMBIC
Filing DateMonday, April 11, 2016
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, July 13, 2020
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 11, 2017

Trademark Statements


Goods and ServicesPharmaceutical preparations and substances used for the treatment of bone, joint, intestine, colon, skin, lung, eye, bladder, blood cells, and blood vessel diseases and disorders; pharmaceutical preparations and substances for the treatment of autoimmune and immune system, inflammatory, inflammatory bowel, gastrointestinal, musculoskeletal, dermatological, pulmonary, respiratory, oncological, and ophthalmic diseases and disorders; pharmaceutical preparations and substances used for the treatment of arthritis, rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, axial spondyloarthritis, juvenile idiopathic arthritis, enthesitis related arthritis, osteoarthritis, peripheral spondyloarthritis, acute disc prolapse, inflammatory bowel disease, Crohn's disease, ulcerative colitis, Intestinal Behçet's Disease, chronic pouchitis, small bowel lesions, Hermansky-Pudlak syndrome, psoriasis, psoriasis vulgaris, psoriasis arthropica, plaque psoriasis, hidradenitis suppurativa, interstitial cystitis, sleep apnea, sarcoidosis, retinal vascular disorders, uveitis, choroidal neovascularization, Pyoderma Gangrenosum, giant cell arteritis, Netherton syndrome, anaplastic thyroid cancers, asthma, and refractory asthma

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, April 15, 2016
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameAmgen Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressThousand Oaks, CA 913201799

Party NameAmgen Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressThousand Oaks, CA 913201799

Trademark Events


Event DateEvent Description
Monday, July 13, 2020ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, July 13, 2020ABANDONMENT - NO USE STATEMENT FILED
Tuesday, November 19, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, November 18, 2019EXTENSION 5 GRANTED
Wednesday, November 13, 2019EXTENSION 5 FILED
Monday, November 18, 2019CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, November 13, 2019TEAS EXTENSION RECEIVED
Tuesday, May 28, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, May 24, 2019EXTENSION 4 GRANTED
Friday, May 24, 2019EXTENSION 4 FILED
Friday, May 24, 2019TEAS EXTENSION RECEIVED
Thursday, March 7, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, March 7, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, November 23, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, November 21, 2018EXTENSION 3 GRANTED
Wednesday, November 21, 2018EXTENSION 3 FILED
Wednesday, November 21, 2018TEAS EXTENSION RECEIVED
Saturday, May 26, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, May 24, 2018EXTENSION 2 GRANTED
Thursday, May 24, 2018EXTENSION 2 FILED
Thursday, May 24, 2018TEAS EXTENSION RECEIVED
Friday, November 17, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, November 15, 2017EXTENSION 1 GRANTED
Wednesday, November 15, 2017EXTENSION 1 FILED
Wednesday, November 15, 2017TEAS EXTENSION RECEIVED
Tuesday, June 6, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 11, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 11, 2017PUBLISHED FOR OPPOSITION
Wednesday, March 22, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, March 3, 2017LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, February 13, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, February 10, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, February 10, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, February 7, 2017ASSIGNED TO LIE
Monday, January 23, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, July 29, 2016NOTIFICATION OF PRIORITY ACTION E-MAILED
Friday, July 29, 2016PRIORITY ACTION E-MAILED
Friday, July 29, 2016PRIORITY ACTION WRITTEN
Tuesday, July 26, 2016ASSIGNED TO EXAMINER
Monday, July 25, 2016ASSIGNED TO EXAMINER
Friday, April 15, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, April 14, 2016NEW APPLICATION ENTERED IN TRAM